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ABSTRACT
We compared two attenuated anticoccidial vaccines, administered to broilers by spray into the incubator (88,000 males
and 210,100 females). Vaccine A container five species of Eimeria and vaccine B three. Zootechnical performance was sim-
ilar in the two groups, with mean lesion scores no higher than 1; vaccine A caused only duodenal lesions, while vaccine B
also caused typhlitis. Maximum oocyst count was 23,000/g feces at age 28 days with vaccine A and 38,000 at 21 days
with vaccine B. Broilers vaccinated with vaccine B had more frequent enteric symptoms, and C. perfringens isolation.
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RIASSUNTO
EFFICACIA IN CAMPO DI DUE VACCINI ANTICOCCIDICI PER BROILERS
Sono stati confrontati due vaccini anticoccidici attenuati in broilers (88.000 maschi e 210.000 femmine) somministrati
per spray in incubatoio. Il vaccino A conteneva 5 specie di Eimeria e il vaccino B 3 specie. Le performance zootecniche
sono state simili nei due gruppi, lo score delle lesioni mediamente non superava il valore 1, anche se A dava lesioni solo
duodenali, mentre con B era presente anche tiflite. L’emissione massima di oocisti era di 23.000 per grammo di feci (OPG)
a 28 gg di vita in A e 38.000 OPG a 21 gg per B. Nei broilers vaccinati con B erano più frequenti sintomi enterici con iso-
lamento di C. perfringens, che ha richiesto terapia specifica per arginare la mortalità.
Parole chiave: Pollo da carne, Coccidiosi, Vaccinazione, Prova di campo.
Introduction
Attenuated anticoccidial vaccines containing
various species of Eimeria pathogenic for poultry
are the only alternative to anticoccidial drugs
(Chapman et al., 2002). Live attenuated vaccines
have been under investigation for several years
now (Shirley, 1989). Most of these consist of a sta-
bilized suspension of sporulated oocysts of Eimeria
species from chickens, selected from precocious
lines (shorter cycle, reduced reproductive poten-
tial, maintenance of the immunogenic capacity).
Another method of attenuation is to produce lines
of coccidia, especially Eimeria tenella, by passages
in embryonated hen’s eggs (Shirley and Bedrník,
1997). The Eimeria lines in commercial vaccines,
even though attenuated, can cause some lesions to
the intestinal mucosa (Williams and Andrews,
2001) and, in less than optimal breeding condi-
tions, these can interact with other intestinal
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pathogens, such as Clostridium perfringens, facili-
tating the onset of pathologies such as necrotic
enteritis (NE) (Waldenstedt et al., 1999).
This study compared the efficacy of two antic-




We used two commercial vaccines, indicated
here as A and B. Vaccine A contained five species
of a precocious line of Eimeria (E. acervulina, E.
maxima (two lines), E. mitis and E. tenella).
Vaccine B container two precocious lines, E.
acervulina and E. maxima, and one egg-adapted
line, E. tenella. Both were administered using a
spray machine (Breuil model), following the man-
ufacturer’s instructions, directly into the incubator
where all the chicks for controlled breeding were
hatched.
Breeding establishments
Eight commercial chicken farms (numbered 1-
8) were checked; four only bred males, and four
only females, for a total of 298,100 broilers (hybrid
ROSS 508). Vaccine A was given to the chicks in
farms nos.1 (26,000 males), 2 (24,000 males), 3
(75,600 females), and 4 (46,000 females). Vaccine B
was given to the chicks in farms nos. 5 (9000
males), 6 (29,000 males), 7 (37,500 females) and 8
(51,000 females). Chicks were housed between
31/05/04 and 10/06/04; the breeding density (male:
10; female: 16 chicks/sq.m) and feed were compa-
rable in all eight farms.
Laboratory tests
From each shed we took 50 individual samples
of feces, and counted the oocysts according to
McMaster’s method on days 7, 14, 21, 28 and 35 for
males and females, and on days 42 and 49 as well
for males. At the ages of 21, 28, 35 days for females
and 21, 28, 35, 42, 49 days for males, we sampled
ten chicks per farm to check for coccidial lesions,
using the method of Johnson and Reid (1970).
From six chicks for each age group we also
removed samples of the intestine (duodenum,
jejunum/ileus and cecum), which were fixed in
10% iso-osmotic formalin and examined histologi-
cally, according to routine methods. Semi-quanti-
tative bacteriological counts were also done on the
same animals, as recommended by Elanco Animal
Health (Anonymous, 2002).
Results and discussion
In the farms where chicks had been given vac-
cine A we found no clinical symptoms of intestinal
pathology, and bedding remained in good condition.
Table 1 shows the scores for lesions. Chicks vacci-
nated with A had few lesions due to E. acervulina
and E. maxima and only very few to E. tenella, in
accordance with the report by Williams and
Andrews (2001). Semi-quantitative examination of
the intestinal flora showed initial mild abnormali-
ty with a prevalence of Gram-negative microorgan-
isms up to day 28; from then onwards until slaugh-
ter there was an increase in C. perfringens, but no
gross or microscopic lesions due NE.
There are, however, reports of interactions
between field coccidia or attenuated anticoccidial
Table 1. Mean lesion scores.
Age E. acervulina E. maxima E. tenella
days Vacc. A Vacc. B Vacc. A Vacc. B Vacc. A Vacc. B
21 0.725 0.65 0.35 0.15 0.1 0.125
28 0.75 0.25 0.55 0.45 0.1 0.575
35 0.15 0 0.45 0 0.2 0.05
42 0 0 0 0 0.02 0.05
49 0 0.15 0 0 0 0
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vaccines and NE (Williams et al., 2003). Output of
oocysts was near-nil in the first two weeks but
peaked at 28 days, as already reported by Williams
and Gobbi (2002), declining steeply thereafter
(Figure 1).
In three of the breeding farms (nos. 6, 7 and 8)
the broilers vaccinated with B had intestinal symp-
toms (catarrhal enteritis), with a rise in mortality,
between the third and fifth weeks. The symptoms
stopped only after repeated antibiotic treatments.
Bacteriological tests in these B-vaccinated chicks
showed a rise in C. perfringens already from the
third week, when oocyst output was maximum –
much higher than in the groups given vaccine A
(Figure 1). The lesion score for vaccine B was not
very different from A, except for the constant find-
ing of lesions due to E. tenella, unlike in the report
by Rois et al. (2002) in similar settings.
Histological lesions in the various segments of
the intestine were correlated to the lesion scores,
subjects B showing more marked cecal lesions,
typical of E. tenella infection.
The productive performances of the two groups
were in line with the specific literature for this
cross. Male and female broilers given vaccine A
were slaughtered respectively at 56.7 and 40.85
days, at average weights of 3.719 kg and 1.676 kg,
with feed conversion ratio (FCR) 1.87 and 1.74,
and mortality 4.05% and 2.46%. Male and female
broilers given vaccine B were slaughtered respec-
tively at 52 and 40.3 days, when average weights
were 3.244 and 1.676 kg, FCR 2.00 and 1.81, and
mortality 6.25 % and 1.78%.
The European Efficiency Index for broilers was
336,54 for group A males and 229,98 for females,
and respectively 292,43 and 225,68 in group B.
Conclusions
Attenuated anticoccidial vaccines are the only
alternatives to the drug prophylaxis that has for
decades permitted the expansion of poultry breed-
ing. These vaccines have been used increasingly in
Italy in recent years. Commercial products are
safe but must obviously be coupled with good
breeding practice for maximum efficiency. The
abolition of growth promoter additives, which con-
trolled the anaerobic intestinal flora, particularly
C. perfringens (Waldenstedt et al., 1999), calls for
care in selecting the right vaccine.
Figure 1. Mean oocyst output in eight broiler breeding farms.
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In this comparison both vaccines effectively
controlled coccidiosis in a field setting. Vaccine A,
given the same breeding conditions and feed,
seemed to interact less on the chicken’s intestinal
microbial flora, without inducing NE, meaning
there was less need for specific antibiotics.
Zootechnical indices were better in Group A, espe-
cially for the males.
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